Stage I Mantle Cell Lymphoma Active Not Recruiting Phase 2 Trials for Vincristine (DB00541)

Also known as: Mantle cell lymphoma stage I

IndicationStatusPhase
DBCOND0029478 (Stage I Mantle Cell Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01527149Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell LymphomaTreatment